2,3-dinor-11β-Prostaglandin F2α (2,3-dinor-11β-PGF2α) is a metabolite of PGD2 . Urinary excretion of 2,3-dinor-11β-PGF2α is increased in patients with mast cell activation disease (MCAD) and has been used as a marker of increased PGD2 levels. 2,3-dinor-11 β-PGF2α levels are also increased in the urine of patients with asthma and are positively correlated with impaired lung function.
2,3-Dinor-11beta-prostaglandin F2alpha (2,3-Dinor-11β-PGF2α) is a metabolite of PGD2. Urinary excretion of 2,3-Dinor-11beta-prostaglandin F2alpha is increased in patients with mast cell activation disease (MCAD) and has been used as a marker of increased PGD2 levels. 2,3-Dinor-11beta-prostaglandin F2alpha levels are also increased in the urine of patients with asthma and are positively correlated with impaired lung function.
ChEBI: 2,3-Dinor-11b-PGF2alpha is a prostanoid.
[1] Liston, et al. J. Biol. Chem. 260(24), 13172-13180 (1985).
